Skip to content
Agree.net – Lifestyle
Author:
IGCS International
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
August 21, 2026
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
Saxon Unmanned Selects IGCS International and Lacks Enterprises for its High-Volume USA Manufacturing Partner for its Platforms
May 10, 2026
Advanced Manufacturing and Strategic Financing Solutions for Defense Drone and Robotics Production
May 6, 2026
IGCS International Announces Strategic Equity Investment by Lacks Enterprises
April 22, 2026